Loading data for IXHL — first visit, this takes a few seconds.
Incannex Healthcare Inc. (IXHL)
NasdaqCM: IXHL
· Real-Time Price · USD
3.64
-0.05 (-1.36%)
At close: Aug 28, 2026, 8:00 PM
3.66
+0.55%
After-hours: 7:30 PM
The price, the headline numbers and the latest news, in one place.
Incannex Healthcare Inc. (IXHL) Stock Price, Analysis & Data
-1.36% (1D)
No data available
| Bid | 2.62 |
| Market Cap | 43.55M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -48.41M |
| 2.81 | |
| -16.31 | |
| n/a | |
| -2.1 | |
| P/B (ttm) | 0.66 |
| P/S (ttm) | n/a |
| Earnings Date | n/a |
| Ask | 4.6 |
| Volume | 42,732 |
| Avg. Volume (20D) | 197,693 |
| Open | 3.70 |
| Previous Close | 3.69 |
| Day's Range | 3.58 - 3.79 |
| 52-Week Range | 2.49 - 20.64 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About IXHL
Incannex Healthcare Inc., a clinical-stage biopharmaceutical company, engages in the research and development of psychedelic medicines and therapies for patients with chronic diseases in Australia. The company develops IHL-42X, an oral fixed dose combination of dronabinol and acetazolamide that is in Phase 2/3 clinical trial for the treatment of obstructive sleep apnea; and PSX-001, an oral synthetic psilocybin treatment in Phase 2b clinical deve...
Sector Healthcare
IPO Date Mar 2, 2022
Employees 12
Stock Exchange NasdaqCM
Ticker Symbol IXHL
Website https://www.incannex.com
Financial Performance
In 2024, Incannex Healthcare's revenue was 12K, an increase of undefined% compared to the previous year's 0. Earnings were -18.46M, a decrease of -62.18%.
Financial StatementsEarnings Surprise
Incannex Healthcare has released their quarterly earnings on May 15, 2026:
- Revenue of $0 misses estimates by $0, with NaN% YoY growth.
- EPS of -0.49 exceeds estimates by 0.35, with 94.78% YoY growth.
